Clinical trial
Safety and Efficacy of Low-dose Cyclosporine in Association With Everolimus to Minimize Renal Dysfunction in Heart Transplant Recipients
NCT00420537 is registered in ClinicalTrials.gov with University of Bologna as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy of Low-dose Cyclosporine in Association With Everolimus to Minimize Renal Dysfunction in Heart Transplant Recipients
- Lead sponsor
- University of Bologna
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- September 30, 2006
- Completion date
- March 31, 2009
- Enrollment
- 34 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
heart transplantation, kidney dysfunction